Literature DB >> 1940988

A case of progressive supranuclear palsy with widespread senile plaques.

S Sasaki1, S Maruyama, C Toyoda.   

Abstract

A case of progressive supranuclear palsy (PSP) with frontal lobe atrophy is reported, in which many senile plaques were widely distributed in the neocortex, the entorhinal cortex, the amygdala, and, to a lesser extent, the cerebellar cortex, but not in the hippocampus. Most of the plaques were of the diffuse and primitive types. They were well visualized by beta-protein immunostaining, modified Bielschowsky staining and methenamine silver staining, but were not seen by Bodian staining. The widespread distribution of senile plaques in the cerebral and cerebellar cortices was far beyond that seen in normal aging, and was reminiscent of concomitant Alzheimer's disease (AD). Unlike AD, however, this case had neither senile changes in the hippocampus nor neurofibrillary tangles in the amygdala and entorhinal cortex. It seems that many senile plaques may appear widely in the cerebral cortex and even, to a lesser extent, in the cerebellar cortex of some patients with PSP. Additional case studies using sensitive silver and amyloid antibody preparations are required to elucidate the presence of senile plaques in the cerebral cortex of PSP.

Entities:  

Mesh:

Year:  1991        PMID: 1940988     DOI: 10.1007/bf00315336

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  34 in total

1.  PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.

Authors:  J C STEELE; J C RICHARDSON; J OLSZEWSKI
Journal:  Arch Neurol       Date:  1964-04

2.  Diffuse type of senile plaques in the brains of Alzheimer-type dementia.

Authors:  H Yamaguchi; S Hirai; M Morimatsu; M Shoji; Y Harigaya
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

3.  Diagnosis of Alzheimer's disease.

Authors:  Z S Khachaturian
Journal:  Arch Neurol       Date:  1985-11

4.  Modified Bielschowsky and immunocytochemical studies on cerebellar plaques in Alzheimer's disease.

Authors:  T Suenaga; A Hirano; J F Llena; H Ksiezak-Reding; S H Yen; D W Dickson
Journal:  J Neuropathol Exp Neurol       Date:  1990-01       Impact factor: 3.685

5.  Distinctive, rapid, and easy labeling of diffuse plaques in the Alzheimer brains by a new methenamine silver stain.

Authors:  H Yamaguchi; C Haga; S Hirai; Y Nakazato; K Kosaka
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

6.  A morphological analysis of senile plaques in the brains of non-demented persons of different ages using silver, immunocytochemical and lectin histochemical staining techniques.

Authors:  D M Mann; A M Brown; D Prinja; D Jones; C A Davies
Journal:  Neuropathol Appl Neurobiol       Date:  1990-02       Impact factor: 8.090

7.  Deposition of amyloid (A4) protein within the brains of persons with dementing disorders other than Alzheimer's disease and Down's syndrome.

Authors:  D M Mann; D Jones
Journal:  Neurosci Lett       Date:  1990-02-05       Impact factor: 3.046

8.  Preamyloid deposits in the cerebral cortex of patients with Alzheimer's disease and nondemented individuals.

Authors:  F Tagliavini; G Giaccone; B Frangione; O Bugiani
Journal:  Neurosci Lett       Date:  1988-11-11       Impact factor: 3.046

9.  Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques.

Authors:  D W Dickson; J Farlo; P Davies; H Crystal; P Fuld; S H Yen
Journal:  Am J Pathol       Date:  1988-07       Impact factor: 4.307

10.  Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques.

Authors:  R Katzman; R Terry; R DeTeresa; T Brown; P Davies; P Fuld; X Renbing; A Peck
Journal:  Ann Neurol       Date:  1988-02       Impact factor: 10.422

View more
  5 in total

1.  Pittsburgh Compound B and AV-1451 positron emission tomography assessment of molecular pathologies of Alzheimer's disease in progressive supranuclear palsy.

Authors:  Jennifer L Whitwell; J Eric Ahlskog; Nirubol Tosakulwong; Matthew L Senjem; Anthony J Spychalla; Ronald C Petersen; Clifford R Jack; Val J Lowe; Keith A Josephs
Journal:  Parkinsonism Relat Disord       Date:  2017-12-13       Impact factor: 4.891

2.  Distribution of cortical neurofibrillary tangles in progressive supranuclear palsy: a quantitative analysis of six cases.

Authors:  P R Hof; A Delacourte; C Bouras
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

3.  Achromatic neurons in the cortex of progressive supranuclear palsy.

Authors:  I R Mackenzie; L P Hudson
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

4.  Tauopathies and synucleinopathies: do cerebrospinal fluid beta-amyloid peptides reflect disease-specific pathogenesis?

Authors:  B Mollenhauer; M Bibl; H Esselmann; P Steinacker; C Trenkwalder; J Wiltfang; M Otto
Journal:  J Neural Transm (Vienna)       Date:  2007-02-22       Impact factor: 3.850

5.  Tau pathology in aged cynomolgus monkeys is progressive supranuclear palsy/corticobasal degeneration- but not Alzheimer disease-like -Ultrastructural mapping of tau by EDX.

Authors:  Toshiki Uchihara; Kentaro Endo; Hiromi Kondo; Sachi Okabayashi; Nobuhiro Shimozawa; Yasuhiro Yasutomi; Eijiro Adachi; Nobuyuki Kimura
Journal:  Acta Neuropathol Commun       Date:  2016-11-14       Impact factor: 7.801

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.